I-Corps alum Assurtek Surgical is commercializing the world’s first AI-powered dental drill technology.
read more
Nanopath is developing molecular diagnostic platforms to detect viral, bacterial, and fungal pathogens using a single patient sample.
read more
This June, an I-Corps cohort of oncology researchers – each working on a cutting-edge solution to improve care and outcomes for cancer patients – took to Chicago for the American Society for Clinical Oncology (ASCO) Annual Meeting to interview clinicians about their biggest problems.
read more
NASA recently collaborated with the Interior Northeast I-Corps Hub (IN I-Corps) to run a specialized NSF I-Corps regional course for wildfire technology management innovators, an initiative that complements the agency’s wildfire management efforts.
read more
For the third year, the Interior Northeast I-Corps Hub (IN I-Corps) led a hybrid I-Corps regional course that included a funded customer discovery trip to the BIO International Convention, the world’s largest biotech industry event.
read more
This January, a regional I-Corps cohort comprised of optics and photonics researchers traveled to San Francisco to explore the market potential of their innovations at SPIE Photonics West, a convention that brings together researchers, engineers, and industry leaders to learn about the latest updates in light-based technologies.
read more
Clairways leverages AI to provide a comprehensive, long-term picture of respiratory health for clinical trials and eventually for pulmonary care.
read more
Reia is redesigning pelvic organ prolapse treatment options to allow women to reclaim their independence and lifestyle.
read more
IN I-Corps hosted a regional course specifically for GEM Fellows as a part of the Inclusion in Innovation Initiative, which aims to increase participation in I-Corps and commercialization activity among STEM researchers across diverse backgrounds.
read more
I-Corps alumni company Nanopath, which spun out of Dartmouth College, recently closed a $10 million Series A funding round. The funding will support development and commercialization of their biosensing platform that transforms how women’s pelvic and gynecologic infections are diagnosed.
read more